We serve Dimethyl Propylmalonate CAS:14035-96-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Dimethyl Propylmalonate
CAS.NO:14035-96-2
Molecular Formula:C8H14O4
Molecular Weight:174.19400
Synonyms:
Dimethyl 2-propylmalonate
Dimethyl propylmalonate
Physical and Chemical Properties:
Density: 1.037g / cm3
Boiling point: 204.4ºC at 760 mmHg
Flash point: 90.8ºC
Refractive index: 1.421
Specification:
Appearance:Clear colorless to yellow liquid
Purity:≥99.0%
Moisture Content: 0.25%
Impurity: 0.3%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.
Contact us for information like Dimethyl Propylmalonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dimethyl propylmalonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dimethyl Propylmalonate Use and application,Dimethyl propylmalonate technical grade,usp/ep/jp grade.
Related News: Thousands of cases have been identified in China, including in every province of the country.2-Butyn-1-ol manufacturer Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.2-Methoxy-5-methyl-N,N-bis(1-methylethyl)-3-phenylbenzenepropanamine fumarate supplier Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.2,2-Dimethylcyclopentanone vendor Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.
